<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01875198</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0138</org_study_id>
    <nct_id>NCT01875198</nct_id>
  </id_info>
  <brief_title>Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      When distal pancreatectomy is carried out for left-sided pancreatic cancer, splenectomy is
      usually performed not only for margin-negative resection but also for effective clearance of
      the splenic hilar lymph nodes. However, there was no scientific evidence regarding the
      justifiability for spleen resection. Considering potential immunological function of the
      spleen, the investigators hypothesized that distal pancreatectomy without pancreatectomy for
      left-sided pancreatic cancer is superior than Distal pancreatectomy with pancreatectomy in
      terms of short-term perioperative outcomes and disease-specific overall survival.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    because of difficulties of enrolling appropriate participants
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding amount</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>average of pain score</measure>
    <time_frame>admission period(about 5 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time interval to adjuvant treatment</measure>
    <time_frame>admission period(about 5 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>admission period(about 5 days)</time_frame>
    <description>(e.g. postoperative pancreatic fistula, delayed gastric emptying, intra-abdominal abscess, postoperative bleeding, wound infection, etc.)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Left-sided Pancreatic Cancer</condition>
  <condition>Ductal Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>RAMPS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radical Antegrade Modular Pancreatectomy with Splenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RAMP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radical Antegrade Modular Pancreatectomy without splenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical Antegrade Modular Pancreatectomy with Splenectomy</intervention_name>
    <arm_group_label>RAMPS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical Antegrade Modular Pancreatectomy without splenectomy</intervention_name>
    <description>distal pancreatectomy without pancreatectomy</description>
    <arm_group_label>RAMP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ductal adenocarcinoma

          2. Age ≥20 and ≤80

          3. General performance status: the Karnofsky score&gt; 70% or ECOG 0-1

          4. Potentially Curative resection

          5. Tumor size &lt; 3cm

          6. Pancreatic cancer located on neck or body portion

          7. No invasion to spleen or spleen hilum

          8. No combined resection except Lt. adrenal gland

          9. Distance more than 5cm (≥5cm) between tumor lateral margin and spleen hilum

        Exclusion Criteria:

          1. Unresectable or locally advanced, metastatic case

          2. Patients who do not want surgery

          3. ASA (American society of anesthesiologists' physical status classification) score: ≥3

          4. Patients with drug or alcohol addiction

          5. Patients showing low compliance

          6. Patients who not want to involve the clinical trial

          7. Patients who are unable to read or understand the informed consent, sign a consent
             form (eg, mental retardation, blindness, illiteracy, foreign, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):375-81. doi: 10.1007/s00534-012-0549-z.</citation>
    <PMID>22911134</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2013</study_first_posted>
  <last_update_submitted>November 19, 2016</last_update_submitted>
  <last_update_submitted_qc>November 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Splenectomy;</keyword>
  <keyword>Spleen-preserving</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

